1. Home
  2. MASS vs PRTC Comparison

MASS vs PRTC Comparison

Compare MASS & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 908 Devices Inc.

MASS

908 Devices Inc.

HOLD

Current Price

$6.16

Market Cap

324.4M

Sector

Health Care

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

N/A

Current Price

$16.70

Market Cap

386.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MASS
PRTC
Founded
2012
2015
Country
United States
United States
Employees
N/A
90
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
324.4M
386.7M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
MASS
PRTC
Price
$6.16
$16.70
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
408.7K
4.8K
Earning Date
11-10-2025
08-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.20
Revenue
$65,045,000.00
$6,391,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$21.54
N/A
P/E Ratio
N/A
$7.94
Revenue Growth
36.21
1265.60
52 Week Low
$1.81
$13.30
52 Week High
$9.34
$24.99

Technical Indicators

Market Signals
Indicator
MASS
PRTC
Relative Strength Index (RSI) 42.84 50.35
Support Level $6.13 $15.50
Resistance Level $6.64 $16.24
Average True Range (ATR) 0.40 0.42
MACD 0.08 0.02
Stochastic Oscillator 58.93 54.88

Price Performance

Historical Comparison
MASS
PRTC

About MASS 908 Devices Inc.

908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: